Cargando…

Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction

Ursodeoxycholic acid (UDCA) is a metabolic by-product of intestinal bacteria, showing hepatoprotective effects. However, its underlying molecular mechanisms remain unclear. The purpose of this study was to elucidate the action mechanisms underlying the protective effects of UDCA and vitamin E agains...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Da Jung, Yoon, Seonghae, Ji, Sang Chun, Yang, Jinho, Kim, Yoon-Keun, Lee, SeungHwan, Yu, Kyung-Sang, Jang, In-Jin, Chung, Jae-Yong, Cho, Joo-Youn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6082879/ https://www.ncbi.nlm.nih.gov/pubmed/30089798 http://dx.doi.org/10.1038/s41598-018-30349-1

Ejemplares similares

Author Correction: Ursodeoxycholic acid improves liver function via phenylalanine/tyrosine pathway and microbiome remodelling in patients with liver dysfunction
por: Kim, Da Jung, et al.
Publicado: (2019)

Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers
por: Yoon, Seonghae, et al.
Publicado: (2014)

Population pharmacokinetic model development and its relationship with adverse events of oxcarbazepine in adult patients with epilepsy
por: Jang, Yoonhyuk, et al.
Publicado: (2021)

Co-administration of ursodeoxycholic acid with rosuvastatin/ezetimibe in a non-alcoholic fatty liver disease model
por: Seo, Sang Hyun, et al.
Publicado: (2022)

Pharmacokinetic characteristics of telaprevir in healthy Korean male subjects and comparisons with Japanese
por: Choi, Yewon, et al.
Publicado: (2018)

Microbiome and Metabolomics in Liver Cancer: Scientific Technology
por: Ganesan, Raja, et al.
Publicado: (2022)

Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects
por: Kim, Yun, et al.
Publicado: (2019)

Pharmacokinetics and tolerability of MB12066, a beta-lapachone derivative targeting NAD(P)H: quinone oxidoreductase 1: two independent, double-blind, placebo-controlled, combined single and multiple ascending dose first-in-human clinical trials
por: Kim, Seokuee, et al.
Publicado: (2017)

Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state
por: Jang, Kyungho, et al.
Publicado: (2014)

Prognosis of liver abscess with no identified organism
por: Yoon, Jai Hoon, et al.
Publicado: (2019)

Synergistic effect of ursodeoxycholic acid on the antitumor activity of sorafenib in hepatocellular carcinoma cells via modulation of STAT3 and ERK
por: Lee, Seulki, et al.
Publicado: (2018)

Pharmacokinetics and Tolerance of the Phage Endolysin-Based Candidate Drug SAL200 after a Single Intravenous Administration among Healthy Volunteers
por: Jun, Soo Youn, et al.
Publicado: (2017)

Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform
por: Kim, Byungwook, et al.
Publicado: (2021)

Recent Advances of Microbiome-Associated Metabolomics Profiling in Liver Disease: Principles, Mechanisms, and Applications
por: Raja, Ganesan, et al.
Publicado: (2021)

Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development
por: Pearson, Talima, et al.
Publicado: (2019)

Adaptation of Phenylalanine and Tyrosine Catabolic Pathway to Hibernation in Bats
por: Pan, Yi-Hsuan, et al.
Publicado: (2013)

Phenylalanine and Tyrosine Kinetics in Critically Ill Children with Sepsis
por: Castillo, Leticia, et al.
Publicado: (1994)

Identification of the Tyrosine- and Phenylalanine-Derived Soluble Metabolomes of Sorghum
por: Simpson, Jeffrey P., et al.
Publicado: (2021)

The Effect of Various Doses of Phenylalanine Supplementation on Blood Phenylalanine and Tyrosine Concentrations in Tyrosinemia Type 1 Patients
por: van Ginkel, Willem G., et al.
Publicado: (2019)

Pathway-Based Integrative Analysis of Metabolome and Microbiome Data from Hepatocellular Carcinoma and Liver Cirrhosis Patients
por: Kim, Boram, et al.
Publicado: (2020)

Liver protective effect of ursodeoxycholic acid includes regulation of ADAM17 activity
por: Buryova, Halka, et al.
Publicado: (2013)

Ursodeoxycholic Acid in Treatment of Non-cholestatic Liver Diseases: A Systematic Review
por: Reardon, Jillian, et al.
Publicado: (2016)

Risk Factors of Glecaprevir/Pibrentasvir-Induced Liver Injury and Efficacy of Ursodeoxycholic Acid
por: Tamai, Hideyuki, et al.
Publicado: (2023)

Protective effect of ursodeoxycholic acid on COVID-19 in patients with chronic liver disease
por: Li, Yanyan, et al.
Publicado: (2023)

Gut commensal Kineothrix alysoides mitigates liver dysfunction by restoring lipid metabolism and gut microbial balance
por: Choi, Kyoung Jin, et al.
Publicado: (2023)

Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease
por: Nadinskaia, Maria, et al.
Publicado: (2021)

Ursodeoxycholic acid inhibits the proliferation of colon cancer cells by regulating oxidative stress and cancer stem-like cell growth
por: Kim, Eun-Kyung, et al.
Publicado: (2017)

Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects
por: Rhee, Su-jin, et al.
Publicado: (2016)

Lipid nanoparticle delivers phenylalanine ammonia lyase mRNA to the liver leading to catabolism and clearance of phenylalanine in a phenylketonuria mouse model
por: Diaz-Trelles, Ramon, et al.
Publicado: (2022)

Development and Testing of Force Field Parameters for Phenylalanine and Tyrosine Derivatives
por: Wang, Xiaowen, et al.
Publicado: (2020)

Synthetic Conjugates of Ursodeoxycholic Acid Inhibit Cystogenesis in Experimental Models of Polycystic Liver Disease
por: Caballero‐Camino, Francisco J., et al.
Publicado: (2020)

The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients
por: Elhini, Sahar H., et al.
Publicado: (2022)

Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjects
por: Yoon, Seonghae, et al.
Publicado: (2015)

Efficacy of Chenodeoxycholic Acid and Ursodeoxycholic Acid Treatments for Refractory Functional Dyspepsia
por: Jang, Sung Ill, et al.
Publicado: (2022)

Matrix metallopeptidases regulate granulosa cell remodeling through the hormone signaling pathway
por: Kim, Sang Hwan, et al.
Publicado: (2020)

Insulin Therapy of Nondiabetic Septic Patients Is Predicted by para-Tyrosine/Phenylalanine Ratio and by Hydroxyl Radical-Derived Products of Phenylalanine
por: Kun, Szilárd, et al.
Publicado: (2015)

Engineered Escherichia coli platforms for tyrosine-derivative production from phenylalanine using phenylalanine hydroxylase and tetrahydrobiopterin-regeneration system
por: Satoh, Yasuharu, et al.
Publicado: (2023)

A new horizon of precision medicine: combination of the microbiome and extracellular vesicles
por: Yang, Jinho, et al.
Publicado: (2022)

Methylglyoxal Induces Mitochondrial Dysfunction and Cell Death in Liver
por: Seo, Kyuhwa, et al.
Publicado: (2014)

Prospective Randomized Trial of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid for Prevention of Radiation-Induced Liver Toxicity
por: Seidensticker, Max, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rklgjvcuaaf006nq7vl3odnpoq